These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 32284914)
1. Risperidone-induced Somnambulism: A Case Report and Brief Review of Literature. Najmi A; Siddiqui F; Ray A; Jhaj R; Sadasivam B Cureus; 2020 Mar; 12(3):e7238. PubMed ID: 32284914 [TBL] [Abstract][Full Text] [Related]
2. A safety signal of somnambulism with the use of antipsychotics and lithium: A pharmacovigilance disproportionality analysis. Gouverneur A; Ferreira A; Morival C; Pageot C; Tournier M; Pariente A Br J Clin Pharmacol; 2021 Oct; 87(10):3971-3977. PubMed ID: 33713370 [TBL] [Abstract][Full Text] [Related]
3. Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study Group. Chouinard G; Kopala L; Labelle A; Beauclair L; Johnson SV; Singh KI Can J Psychiatry; 1998 Dec; 43(10):1018-25. PubMed ID: 9868567 [TBL] [Abstract][Full Text] [Related]
4. Olanzapine: an updated review of its use in the management of schizophrenia. Bhana N; Foster RH; Olney R; Plosker GL Drugs; 2001; 61(1):111-61. PubMed ID: 11217867 [TBL] [Abstract][Full Text] [Related]
5. Olanzapine-Related Somnambulism: A Systematic Review of Literature and a Case Report of Anorexia Nervosa. de Filippis R; Guinart D; Rania M; Carbone EA; Gaetano R; Segura-Garcia C J Clin Psychopharmacol; 2021 Nov-Dec 01; 41(6):658-666. PubMed ID: 34668875 [TBL] [Abstract][Full Text] [Related]
6. New generation antipsychotics for first episode schizophrenia. Rummel C; Hamann J; Kissling W; Leucht S Cochrane Database Syst Rev; 2003; (4):CD004410. PubMed ID: 14584012 [TBL] [Abstract][Full Text] [Related]
7. Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia. Gaebel W; Riesbeck M; Wölwer W; Klimke A; Eickhoff M; von Wilmsdorff M; Jockers-Scherübl MC; Kühn KU; Lemke M; Bechdolf A; Bender S; Degner D; Schlösser R; Schmidt LG; Schmitt A; Jäger M; Buchkremer G; Falkai P; Klingberg S; Köpcke W; Maier W; Häfner H; Ohmann C; Salize HJ; Schneider F; Möller HJ; J Clin Psychiatry; 2007 Nov; 68(11):1763-74. PubMed ID: 18052570 [TBL] [Abstract][Full Text] [Related]
10. Clinical experience in developing treatment regimens with the novel antipsychotic risperidone. Kopala LC Int Clin Psychopharmacol; 1997 Sep; 12 Suppl 4():S11-8. PubMed ID: 9352341 [TBL] [Abstract][Full Text] [Related]
11. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia. Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670 [TBL] [Abstract][Full Text] [Related]
12. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
13. Effects of low-dose risperidone and low-dose zuclopenthixol on cognitive functions in first-episode drug-naive schizophrenic patients. Fagerlund B; Mackeprang T; Gade A; Glenthøj BY CNS Spectr; 2004 May; 9(5):364-74. PubMed ID: 15115949 [TBL] [Abstract][Full Text] [Related]
14. [Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms]. Menard ML; Yagoubi F; Drici M; Lavrut T; Askenazy F Encephale; 2013 May; 39 Suppl 1():S29-35. PubMed ID: 23219595 [TBL] [Abstract][Full Text] [Related]
15. Risperidone. A pharmacoeconomic review of its use in schizophrenia. Foster RH; Goa KL Pharmacoeconomics; 1998 Jul; 14(1):97-133. PubMed ID: 10182198 [TBL] [Abstract][Full Text] [Related]